Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

SURAKSHA DIAGNOSTIC LTD.

NSE : SURAKSHABSE : 544293ISIN CODE : INE877V01027Industry : Hospital & Healthcare ServicesHouse : Private
BSE355.300.55 (+0.16 %)
PREV CLOSE () 354.75
OPEN PRICE () 355.35
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 25613
TODAY'S LOW / HIGH ()349.10 366.50
52 WK LOW / HIGH ()328.45 449
NSE357.301.95 (+0.55 %)
PREV CLOSE() 355.35
OPEN PRICE () 355.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 357.30 (132)
VOLUME 177951
TODAY'S LOW / HIGH() 348.40 367.00
52 WK LOW / HIGH ()328.6 449
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 2005

Management Info :

Somnath Chatterjee - Chairman - Managing Director

Registered Office :

Address : Plot No D G-12/1, Action Area 1 D,Premises No 02-0327, New Town,Rajarhat,
Kolkata,
West Bengal-700156

Phone : 033-66059750

Registrar's Details : K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
NEWS
26Dec Suraksha Diagnostic informs about clos
Pursuant to provisions of SEBI (Prohibition of Insider Trading) Regulati..
21Dec Suraksha Diagnostic informs about inve
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..
21Dec Suraksha Diagnostic informs about inve
Suraksha Diagnostic has informed that pursuant to Regulation 30(6) of th..
21Dec Suraksha Diagnostic informs about new
Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Re..
20Dec Notice of Postal Ballot
Inter alia, approved:- 1. Postal Ballot Notice for seeking shareholders..
Financials
in Millions
QTR Sep 24 ANNUAL
Net Profit107.46
Gross Profit 141.78
Operating Profit 248.29
Net Sales
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Dr Agarwals Eye Hsp (BSE)
 6817.25 (0.47%)
M.Cap ( in Cr)
3210.57
Kovai Medical Center (BSE)
 5823.20 (0.50%)
M.Cap ( in Cr)
6434.05
Krsnaa Diagnostics (BSE)
 870.35 (0.57%)
M.Cap ( in Cr)
2782.57
NG Industries (BSE)
 173.40 (2.79%)
M.Cap ( in Cr)
58.10
GPT Healthcare (BSE)
 177.25 (2.34%)
M.Cap ( in Cr)
1466.73
Shareholding Pattern
PROMOTERS 48.78%
MUTUAL FUNDS/UTI 17.64%
NON-INSTITUTION 15.39%
FI/BANKS/INSURANCE 0.31%
GOVERNMENT 0%
FII 0%
Mf Holding
Scheme NameHold(%)
No Data Found
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX76724.08224.45 (0.29%)
NIFTY23213.2037.15 (0.16%)
Dow Jones 42518.28221.16 (0.52%)
Nasdaq 19044.39-43.71 (-0.23%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI